Johnson & Johnson (JNJ)

164.21
0.40 0.24
NYSE
Prev Close 163.81
Open 164.61
Day Low/High 164.24 / 165.98
52 Wk Low/High 133.65 / 179.92
Volume 6.04M
Exchange NYSE
Shares Outstanding 2632.48B
Market Cap 433.70B
P/E Ratio 28.74
Div & Yield N.A. (N.A)
My Greatest Concern About Procter & Gamble Heading Into Earnings

My Greatest Concern About Procter & Gamble Heading Into Earnings

Volatility appears to be the most attractive play during the early portion of earnings season.

Two Sticking Points With Johnson & Johnson: Guidance and Litigation Expense

Two Sticking Points With Johnson & Johnson: Guidance and Litigation Expense

While the ongoing litigation could be seen as a deterrent to investment, I think the more interesting story is its upcoming AFib detection study with Apple.

Johnson & Johnson: How the Stock Looks on the Charts After Earnings

Johnson & Johnson: How the Stock Looks on the Charts After Earnings

Experienced traders could approach the long side carefully.

The Meat and Potatoes of This Global Economic Slowdown: Market Recon

The Meat and Potatoes of This Global Economic Slowdown: Market Recon

It's centered around a few themed negatives, all forcing their own various uncertainties into free market price discovery.

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

One of pharma's biggest CEO's talks M&A action on the exchange.

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Do we have to run for the hills? Not necessarily.

A Johnson & Johnson Volatility Trade

A Johnson & Johnson Volatility Trade

JNJ's current pennant pattern creates the potential for a big move in the month of January.

Johnson & Johnson Stock May Take a While to Rebound From Talc Hit

Johnson & Johnson Stock May Take a While to Rebound From Talc Hit

Shares have fallen hard, despite the company's vehement scientific and legal defense.

Johnson & Johnson Remains Dividend Stock Royalty

Johnson & Johnson Remains Dividend Stock Royalty

Despite recent talc powder risks, the long-term earnings power of this 'Dividend King' has not deteriorated.

Jim Cramer: This Is a Treacherous Bear Market

Jim Cramer: This Is a Treacherous Bear Market

But even in bear markets you get spikes, usually short sharp ones.

It's Ugly Out There: Here's What I Suggest Traders Do Right Now

It's Ugly Out There: Here's What I Suggest Traders Do Right Now

We are absolutely due for a rip-your-face-off rally in the wake of entering a bear market.

Now Is the Time to Play Defense

Now Is the Time to Play Defense

Remember, though, playing defense is very different than leaving the stadium altogether.

Jim Cramer: My Take on These Companies Where Lawsuits Are Front and Center

Jim Cramer: My Take on These Companies Where Lawsuits Are Front and Center

These are currently situations where companies are facing serious lawsuits.

Are Algos Jumping on J&J Headlines?

Are Algos Jumping on J&J Headlines?

Are machines jumping on Johnson & Johnson's human risk headlines?

Chart of the Day: Johnson & Johnson's Punishment Appears Overdone

Chart of the Day: Johnson & Johnson's Punishment Appears Overdone

Putting J&J stock's selloff in a graphic illustrates the market's swift and violent reaction to the Reuters report.

Johnson & Johnson Challenges Reuters' Assertions About Its Product Safety

Johnson & Johnson Challenges Reuters' Assertions About Its Product Safety

Shares continue to fall on Monday after Friday's swift descent.

Let's Get Real About Johnson & Johnson's Selloff and How to Play the Stock

Let's Get Real About Johnson & Johnson's Selloff and How to Play the Stock

I find a lot of Reuters' claims hard to believe. Even more difficult to believe is the selloff.

Johnson & Johnson Stock Presents a Buying Opportunity Amid an Overblown Selloff

Johnson & Johnson Stock Presents a Buying Opportunity Amid an Overblown Selloff

Many analysts advise buying the shares on weakness because it's attractively priced.

Johnson & Johnson - Round 2 - More Selling Pressure

Johnson & Johnson - Round 2 - More Selling Pressure

JNJ ended the day and week in a vulnerable position and we are seeing further weakness today.

Interest in Johnson & Johnson Stock Dries Up Amid Baby Powder Scandal

Interest in Johnson & Johnson Stock Dries Up Amid Baby Powder Scandal

The market appears to still be spooked by JNJ as shares are set to open at their lowest level since July amid the Reuters articles fallout.

Jim Cramer: Trust This Market? It Remains Treacherous

Jim Cramer: Trust This Market? It Remains Treacherous

Now the unnerving thing about this market is that when it gets on a negative roll it blows through all convention.

Investors No Longer Trust Growth, Plus How to Play JNJ: Market Recon

Investors No Longer Trust Growth, Plus How to Play JNJ: Market Recon

While headline-chasing algorithms alter expected outcomes based on fundamental analysis, technical analysis remains valid.

Johnson & Johnson Breaks Down Sharply on the Charts So Take Action

Johnson & Johnson Breaks Down Sharply on the Charts So Take Action

Johnson & Johnson has survived some unfortunate news events in the past, but I would not take that as a good technical reason to hold the stock.

Jim Cramer: I Can't Tell You to Buy This Market

Jim Cramer: I Can't Tell You to Buy This Market

I am urging you to think a little more long-term.

Helmets and Flak Jackets

Unimpressed Equity markets headed lower as the regular Friday trading session extended into it's second and third hours. The way down has been led, not by Adobe , not by Costco , but by Johnson & Johnson . I have been known to make limited attempts ...

Jim Cramer: The Operative Term for This Tape Is Treacherous

Jim Cramer: The Operative Term for This Tape Is Treacherous

Use it to your advantage or don't use it at all.

Jim Cramer: Don't Throw Away These Stocks

Jim Cramer: Don't Throw Away These Stocks

It's done without much thought even though their companies are doing amazingly well.

3 Tips for Trading the Fed's More Dovish Stance

3 Tips for Trading the Fed's More Dovish Stance

Anticipating a weaker dollar thanks to the shift in the Fed, which stocks are most likely to benefit?